SaPI1 Interference and
Bacteriophage 80a
Capsid Size Determination
Introduction
Bacterial
pathogenicity islands (PIs) are genetic elements containing nonessential genes,
often related to virulence. These islands are speculated to be highly motile
due to characteristic flanking direct repeats (such as IS elements) and
intergrase homologues. Staphylococcus aureus contains numerous PIs
including SaPI1, which carries the gene encoding the toxic shock syndrome toxin
(TSST-1). SaPI1 is 15.2 Kb in length and contains flanking 17 bp direct
repeats. In addition to tst, the gene for TSST-1, SaPI1 has a gene for
another superantigen, sek, as well as a partial sequence of a third, sel.
An int homologue is present, which allows for the integration of the
element into the S. aureus chromosome. Also noted is ter, which
creates a protein similar to the terminases of several other phages. Other than
these genes, the function of the other ORFs present in SaPI1
are unknown.
Ordinarily SaPI1 is
stable while integrated in the S. aureus chromosome, but the presence of
bacteriophage 80a will cause the excision, replication, and
packaging of SaPI1 into phage-like particles. Excision of the SaPI1 genome
cannot happen in the absence of phage 80a, suggesting that
a phage-encoded function is needed for motility. These SaPI1 particles are
smaller than those packaging 80a DNA,
and the transduction frequency of SaPI1 through these elements is extremely
high.
The observed
interference of SaPI1 in the lytic growth and packaging of 80a is speculated to be controlled by the PI itself. Although the
mechanism for interference by SaPI1 is unknown, one model is provided by
previous studies with the P4/P2 coliphages. Without the presence of P2, P4
exists in E. coli as a plasmid or prophage. Superinfection with P2
allows lytic growth of P4. P4 capsid particles are composed of the same protein
monomers as those of P2, but P4 is able to control the assemblage of these
proteins by way of the protein Sid This results in a
smaller head only capable of packaging the smaller P4 genome. Because of
similarities between the SaPI1-80a and P4-P2
systems, it is worth investigating the unknown ORFs of SaPI1 for a gene
responsible for this packaging interference.
Pathogenicity island
SaPIn3, found in S. aureus strain
N315, has recently been investigated for small RNAs
(sRNAs) which are primarily translation regulators. Seven different sRNAs were
found to be expressed in the PI and some of these expression levels varied
greatly among pathogenic strains. This variation suggests their importance in
the regulation of S. aureus virulence
elements.
Progress Report
Orf1 of SaPI1 was
successfully cloned into the vector plasmid pCN51 and electroporated into a
SaPI1-clean strain of S. aureus. Orf2
and orf3 were well on their way to being cloned as well when this method was
abandoned due to problems with pCN51 expression in S. aureus strains. Other projects in the lab using pCN51 were
unable to induce adequate expression of protein using this vector, so a new
plasmid will be used: pPV72. Also, instead of cloning each orf individually, a
large section of SaPI1 will be investigated to accelerate the process.
Methods
Orf15 of SaPI1 is a
homologue to a phage helicase, a protein which is typically expressed early in
phage expression. Because early, middle, and late genes tend to be clustered
together in phage, orfs 17-21 are most likely involved with early gene
expression. Capsid construction happens during the late stage of phage
expression, so the gene interfering is most likely to be found with late genes.
Therefore, the region from orf11 to ter
(small terminase subunit) will be cloned (Fig. 1). Small terminase is involved
in capsid head packaging, again suggesting the presence of late expressed genes
in that region of SaPI1. Primers were designed from the end of the tst gene to the end of orf15 to be sure
any promoter and terminator sequences for the region are included. The PCR
product will then be digested with Pst 1 and ligated into pPV72. Plasmid pPV72
is an E. coli, S. aureus shuttle vector allowing tetracycline selection in both
species.
The S. aureus strain containing the vector
with insert will then be infected with 80a and
plated alongside a control strain without the plasmid. Significant difference
in pfu (plaque-forming units) would indicated disruption in
80a capsid formation as the copies of 80a genomic DNA packaged would be reduced. If such a
disruption were seen, primers would then be designed internally within the tst-orf11 region to narrow down the
location of the gene responsible for this disruption. If no disruption is seen
initially, then another region of SaPI1 will be explored.
Also,the
entire SaPI1 sequence will be searched for regions of simularity to the sRNA
sequences found in SaPIn3. These sequences were found in intergenic (noncoding
regions) so areas between ORFs will be focused on primarily.
Possible Results
Hopefully, by using
this whole region approach instead of orf by orf, I will be able to locate the
region containing the gene by the end of the summer. If all goes well, I will
have it down to the exact orf itself responsible for the capsid interference. The
vector should not give any problems, since it is not an expression plasmid, I
am using the promoters on SaPI1 itself. The only big hurdle will be getting the
first PCR amplification of an almost 5 Kb region. If this proves to be
unrealisitic, then I will go ahead and design the internal primers to split the
region in half.
References
Appl Environ Microbiol.
70(10): 6076-6085.
Lindqvist B.H., Deho G., and Calendar R., (1993)
Mechanisms of genome propagation and helper exploitation by satellite phage P4. Microbiology. Rev. 57: 683- 702.
Novick, R.P. (2002)
Pichon C., and Feldon B. (2005) Small RNA
genes expressed from Staphylococcus
aureus genomic and pathogenicity islands with specific expression among pathogenic strains. PNAS. 102(40): 14249-14254.
Ruzin A., Lindsay J., and Novick R.P. (2002)
Molecular genetics of SaPI1 - a mobile pathogenicity island in Staphylococcus
aureus. Molecular Microbiology 41(2): 365-377.